UBS has downgraded BHEL to "Neutral" from "Buy", citing a more balanced risk-reward outlook after the stock's strong run, though it raised the target price to Rs 460 from Rs 375, implying about 14% upside. The brokerage believes much of BHEL's order book growth is already reflected in the stock price.
UBS downgrades BHEL shares to Neutral from Buy. Check target, key reasons
UBS has downgraded BHEL to “Neutral” from “Buy”, citing a more balanced risk-reward outlook after the stock’s strong run, though it raised the target price…
